Jack Nathan Medical Corp.
JNH.V
TSX
| 04/30/2025 | 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.40M | -3.19M | 3.84M | 3.94M | 1.53M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.40M | -3.19M | 3.84M | 3.94M | 1.53M |
| Cost of Revenue | 239.70K | -846.80K | 705.00K | 839.40K | 241.10K |
| Gross Profit | 1.16M | -2.34M | 3.14M | 3.10M | 1.29M |
| SG&A Expenses | 1.70M | -2.94M | 3.84M | 4.06M | 1.72M |
| Depreciation & Amortization | 32.60K | -343.30K | 233.90K | 242.20K | 61.50K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.98M | -4.13M | 4.78M | 5.14M | 2.02M |
| Operating Income | -576.80K | 943.10K | -931.00K | -1.20M | -488.50K |
| Income Before Tax | -581.70K | 1.71M | -1.32M | -1.70M | -465.60K |
| Income Tax Expenses | 109.70K | 26.00K | -- | -- | -14.50K |
| Earnings from Continuing Operations | -691.40K | 1.68M | -1.32M | -1.70M | -451.10K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -691.40K | 8.72M | -1.32M | -1.70M | -451.10K |
| EBIT | -576.80K | 943.10K | -931.00K | -1.20M | -488.50K |
| EBITDA | -560.00K | 990.90K | -748.70K | -1.02M | -302.70K |
| EPS Basic | -0.01 | 0.10 | -0.02 | -0.02 | -0.01 |
| Normalized Basic EPS | 0.00 | 0.01 | -0.01 | -0.01 | 0.00 |
| EPS Diluted | -0.01 | 0.10 | -0.02 | -0.02 | -0.01 |
| Normalized Diluted EPS | 0.00 | 0.01 | -0.01 | -0.01 | 0.00 |
| Average Basic Shares Outstanding | 87.10M | 87.10M | 87.10M | 87.10M | 87.10M |
| Average Diluted Shares Outstanding | 87.10M | 87.43M | 96.10M | 87.10M | 87.10M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |